Zheng Quan Shi Bao Wang·2025-08-26 09:40Group 1 - The CRO concept sector experienced a decline of 2.00%, ranking among the top declines in concept sectors, with notable declines in companies such as Yangguang Nuohuo, Meihao Medical, and Haitai Biological [1][2] - Among the 49 stocks in the CRO sector, 13 stocks saw price increases, with Tai Long Pharmaceutical, Puni Testing, and ST Weiming leading the gains at 5.39%, 2.84%, and 1.10% respectively [1][2] - The CRO sector faced a net outflow of 3.065 billion yuan in capital, with Han Yu Pharmaceutical experiencing the largest outflow of 766.13 million yuan, followed by WuXi AppTec and Kanglong Chemical with outflows of 706.94 million yuan and 169.89 million yuan respectively [2][4] Group 2 - The top gainers in the CRO sector included Lianhua Technology, Meinuo Pharmaceutical, and Tai Long Pharmaceutical, with net inflows of 17.76 million yuan, 17.24 million yuan, and 11.20 million yuan respectively [2][4] - The CRO concept sector's performance was contrasted with other sectors, such as the Tonghuashun Fruit Index which increased by 3.11%, and the chicken farming sector which rose by 2.87% [2][3] - The trading volume and turnover rates varied significantly among the stocks, with Han Yu Pharmaceutical showing a turnover rate of 16.12% alongside a price drop of 5.94% [3][4]